← Neuromodulation for Chronic Abdominal Discomfort Syndrome: Targets, Techniques, and Outcomes

← Full program

Overview: Chronic Abdominal Pain Disorders (CADS) and Neuromodulation Rationale

Part of Neuromodulation for Chronic Abdominal Discomfort Syndrome: Targets, Techniques, and Outcomes

Details

Date
Friday, January 22, 2027
Time
10:51 AM – 11:06 AM
Room
Milano Ballroom VII & VIII
Session type
Concurrent Session
Schedule
See this day

About

Chronic Abdominal Discomfort Syndrome (CADS) represents a newly defined clinical entity characterized by persistent abdominal pain without clear structural pathology yet associated with visceral afferent sensitization and central modulation dysfunction. Neuromodulation - targeting DRG (T11-L2), splanchnic nerves, and celiac plexus pathways -offers a promising therapeutic strategy for select phenotypes. However, standardized patient selection, programming strategies, and long-term durability data remain limited. This session provides a structured, phenotype-based approach to visceral neuromodulation.

Faculty

  • Nebojsa Nick Knezevic, MD, PhD

    Nebojsa Nick Knezevic, MD, PhD

    Vice Chair for Research and Clinical Professor

    Advocate Illinois Masonic Medical Center and University of Illinois · Chicago, Illinois